Zhang Z, Hu D, Xu W, Wu T, Gao L, Yang C. Structural OCT Changes Following Repeated Low-Level Red-Light Therapy for Myopia Prevention. JAMA Ophthalmol. Published online August 21, 2025. doi:10.1001/jamaophthalmol.2025.2767
Evans, Bruce J W et al. “Increasing myopia in Scotland at age of 3.5-5.5 years: A retrospective epidemiological study.” Ophthalmic & physiological optics : the journal of the British College of Ophthalmic Opticians (Optometrists) vol. 45,3 (2025): 834-844. doi:10.1111/opo.13461
Myopia Workflow Masterclass
Xu S, Wang M, Qu Y, Wang Y, Jiang J, Zhou F, et al. Twice-daily administration improves the effectiveness of 0.01% atropine for controlling myopia in slowing axial elongation and refractive progression. Ophthalmic Physiol Opt. 2025; 00: 1–11.
Xu H, Chen M, Ye L, et al. Orthokeratology, 0.04% Atropine, and 0.01% Atropine for Myopia Control: A Randomized Clinical Trial. JAMA Ophthalmol. Published online July 24, 2025.
PASEK NARZĘDZI DOSTĘPNOŚCI